Gene: S100PBP
Official Full Name: S100P binding proteinprovided by HGNC
Gene Summary: This gene encodes a protein that was originally identified by its interaction with S100 calcium-binding protein P. Expression of this protein has been reported to be associated with pancreatic ductal adenocarcinoma. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14375 | S100PBP Knockout cell line (HeLa) | Human | S100PBP | 1:3~1:6 | Negative | Online Inquiry |
KO14376 | S100PBP Knockout cell line (HCT 116) | Human | S100PBP | 1:2~1:4 | Negative | Online Inquiry |
KO14377 | S100PBP Knockout cell line (HEK293) | Human | S100PBP | 1:3~1:6 | Negative | Online Inquiry |
KO14378 | S100PBP Knockout cell line (A549) | Human | S100PBP | 1:3~1:4 | Negative | Online Inquiry |
S100PBP Gene Knockout Cell Lines are genetically modified cell lines with the S100PBP gene specifically disrupted to enable in-depth research into the gene's functions, interactions, and implications in various biological processes. These knockout cell lines serve as a crucial tool for scientists investigating the role of S100PBP in cellular signaling, cancer biology, and inflammatory responses, providing a unique system for examining molecular pathways that mediate physiological and pathological processes.
The S100PBP protein is a member of the S100 family of calcium-binding proteins, which are known to participate in numerous cellular functions, including cell cycle progression, differentiation, and apoptosis. By utilizing S100PBP Gene Knockout Cell Lines, researchers can elucidate the specific contributions of this protein to intracellular signaling cascades and its interaction with various cellular molecules. The absence of functional S100PBP allows for a clearer understanding of its role, paving the way for potentially novel therapeutic targets in diseases linked to its dysregulation.
The scientific importance of these cell lines is underscored by their application in both basic and applied research environments. In clinical settings, the understanding gained from S100PBP studies may contribute to advancements in cancer therapies or treatments for chronic inflammatory diseases. Moreover, the study of knockout lines can lead to insights into the general mechanisms underlying protein function and gene regulation, thereby enriching the fields of molecular biology and genetics.
What sets our S100PBP Gene Knockout Cell Lines apart from conventional cell lines is their guaranteed specificity, validated gene editing, and robust performance across a variety of experimental conditions. Researchers benefit from the direct and reliable results obtained from these specialized lines, facilitating breakthroughs that may not be achievable with wild-type cell lines or less specific knockout models.
In summary, these gene knockout cell lines represent an invaluable resource for researchers and clinicians dedicated to advancing their understanding of S100PBP-related mechanisms. Our company prides itself on delivering high-quality biological products that empower scientific innovation, backed by our deep expertise and commitment to excellence in genetic engineering and cell line development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.